We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AVI BioPharma Initiates Clinical Studies for Two RNA-Based Therapeutic Candidates for Treatment of Ebola and Marburg Viruses

Product News   May 05, 2011

 
AVI BioPharma Initiates Clinical Studies for Two RNA-Based Therapeutic Candidates for Treatment of Ebola and Marburg Viruses
 
 
FURTHER INFORMATION
 
 
 

Related Product News


IDT Premieres Leading NGS Lineup and Expertise in Europe

Product News

Comprehensive, powerful and flexible NGS offering showcased at ESHG.

READ MORE

ERS Genomics Licenses CRISPR Gene Editing Technology to Bioneer to Further Advance Preclinical Disease Modelling

Product News

ERS Genomics Limited and Bioneer A/S today announced the signing of a license agreement providing Bioneer access to CRISPR/Cas9 genome editing technology intellectual property.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE